Dobutamine Stress Echo For Myocardial Viability Assessment

  • Ignatius Yansen Departement of Cardiology and Vascular Medicine, Faculty of Medicine University of Indonesia National Cardiovascular Center Harapan Kita, Jakarta
  • Amiliana Mardiani Departement of Cardiology and Vascular Medicine, Faculty of Medicine University of Indonesia National Cardiovascular Center Harapan Kita, Jakarta
  • Ario Soeryo Kuncoro Departement of Cardiology and Vascular Medicine, Faculty of Medicine University of Indonesia National Cardiovascular Center Harapan Kita, Jakarta

Abstract

The prevalence of left ventricular (LV) dysfunction and resultant heart failure is increasing in developing countries. Two thirds of cases of left ventricular dysfunction are the result of coronary artery disease (CAD).
Although there have been significant advances in medical therapy for LV dysfunction and resulting symptoms of heart failure, the prognosis from heart failure remains extremely poor. Many of these patients had previous myocardial infarctions, the extent of remaining viable tissue is of clinical interest, and also related to prognosis. Thus assessing myocardial viability is very important in patient with left verntricuar dysfunction to choose the right management. Dobutamine stress echo is one of the most common tool that used to asses myocardial viability.
A 67 years old patient with chronic heart failure because of old anterior and inferior MCI with low ejection fraction. It is very important to assess the viability in patients with advanced heart failure to know the future management because it is related to patient’s morbidity and mortality. With little viable myocard in this patient, the best management for this patient is conservative therapy with medical therapy. Dobutamine stress echocardiography therefore, may well provide complementary information in the assessment of myocardial viability. Future modalities are now being studied to give more objective measurement of myocardial viability with higher sensitivity and specificity.

Downloads

Download data is not yet available.

References

Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2002;39(7):1159-1162.

Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med. 1998;339(3):173-181.

Heusch G, Schulz R, Rahimtoola SH. Myocardial hiberna-tion: a delicate balance. Am J Physiol Heart Circ Physiol. 2005;288(3):H984-999.

Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, de Lentdecker P, Bachet J, Goudot B, Guilmet D. Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg. 1994;57(6):1402-1407; discussion 1407-1408.

Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dys-function: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151-1158.

La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23(3):617-626.

Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91(3):663-670.

Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocar-diography. J Am Soc Echocardiogr. 2007;20(9):1021-1041.

Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly MG, Winters WL, Jr., Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Jr. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106(14):1883-1892.

Sadeghian H, Majd-Ardakani J, Lotfi-Tokaldany M, Jahangiri C, Fathollahi MS. Comparison between dobutamine stress echocardiography and myocardial perfusion scan to detect viable myocardium in patients with coronary artery disease and low ejection fraction. Hellenic J Cardiol. 2009;50(1):45-51.

Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roe-landt JR, Poldermans D. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocar-diography? Eur Heart J. 2003;24(9):789-800.

Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, Roelandt JR, Fioretti PM. Improvement of left ven-tricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34(1):163-169.

Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 1998;32(4):921-926.

Baumgartner H, Porenta G, Lau YK, Wutte M, Klaar U, Mehrabi M, Siegel RJ, Czernin J, Laufer G, Sochor H, Schelbert H, Fishbein MC, Maurer G. Assessment of myo-cardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol. 1998;32(6):1701-1708.

Nishino M, Tanouchi J, Tanaka K, Ito T, Kato J, Iwai K, Ta-nahashi H, Hori M, Yamada Y, Kamada T. Dobutamine stress echocardiography at 7.5 mg/kg/min using color tissue Doppler imaging M-mode safely predicts reversible dysfunction early after reperfusion in patients with acute myocardial infarction. Am J Cardiol. 1999;83(3):340-344.

Jun T, Hirono O, Kubota I, Okuyama M, Fukui A, Yamaki M, Tomoike H. Dobutamine stress echocardiography for the diagnosis of myocardial viability: assessment of left ventricular systolic velocities in longitudinal axis by pulsed Doppler tissue imaging. Jpn Heart J. 2000;41(4):435-443.

Pavlopoulos H, Nihoyannopoulos P. Strain and strain rate deformation parameters: from tissue Doppler to 2D speckle tracking. Int J Cardiovasc Imaging. 2008;24(5):479-491.
Views & Downloads
Abstract views: 885   
PDF downloads: 638   
How to Cite
Yansen, I., Mardiani, A., & Kuncoro, A. (1). Dobutamine Stress Echo For Myocardial Viability Assessment. Indonesian Journal of Cardiology, 32(2), 96-106. https://doi.org/10.30701/ijc.v32i2.106
Section
Case Reports